Stay updated on Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new site revision marker 'Revision: v3.4.2' was added and the previous 'Revision: v3.4.1' marker was removed. These are routine site maintenance/versioning updates and do not affect study content or availability; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:34:38.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Administrative notices were added: a government funding lapse notice with status guidance, and a software revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:23:25.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary display is now shown, and new metadata labels include Last Update Submitted that Met QC Criteria and Last Update Posted. The revision label has been updated to v3.4.0, and older labels such as Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), and No FEAR Act data have been removed or renamed.
    Difference
    0.2%
    Check dated 2026-01-28T03:53:56.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous v3.3.3 on the page. This is a minor update that does not affect study content or user-facing information; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:03:56.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Locations have been added by state (CA, DC, GA, MN, MO, NJ, NY, OH, TX) under a new Locations section; the HHS Vulnerability Disclosure link was removed, and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T21:33:21.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Added a PubMed auto-fill publication notice and updated the revision from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:16:26.000Z thumbnail image

Stay in the know with updates to Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page.